Advanced glycation end products induce neural tube defects through elevating oxidative stress in mice
Authors:
Open Access
- 1 January 2018
- journal article
- research article
- Published by Medknow in Neural Regeneration Research
- Vol. 13 (8) , 1368-1374
Abstract
Our previous study showed an association between advanced glycation end products (AGEs) and neural tube defects (NTDs). To understand the molecular mechanisms underlying the effect of AGEs on neural tube development, C57BL/6 female mice were fed for 4 weeks with commercial food containing 3% advanced glycation end product bovine serum albumin (AGE-BSA) or 3% bovine serum albumin (BSA) as a control. After mating mice, oxidative stress markers including malondialdehyde and H2O2 were measured at embryonic day 7.5 (E7.5) of gestation, and the level of intracellular reactive oxygen species (ROS) in embryonic cells was determined at E8.5. In addition to evaluating NTDs, an enzyme-linked immunosorbent assay was used to determine the effect of embryonic protein administration on the N-(carboxymethyl) lysine reactivity of acid and carboxyethyl lysine antibodies at E10.5. The results showed a remarkable increase in the incidence of NTDs at E10.5 in embryos of mice fed with AGE-BSA (no hyperglycemia) compared with control mice. Moreover, embryonic protein administration resulted in a noticeable increase in the reactivity of N-(carboxymethyl) lysine and N(ε)-(carboxyethyl) lysine antibodies. Malondialdehyde and H2O2 levels in embryonic cells were increased at E7.5, followed by increased intracellular ROS levels at E8.5. Vitamin E supplementation could partially recover these phenomena. Collectively, these results suggest that AGE-BSA could induce NTDs in the absence of hyperglycemia by an underlying mechanism that is at least partially associated with its capacity to increase embryonic oxidative stress levels.Keywords
This publication has 53 references indexed in Scilit:
- Epidemiologic and genetic aspects of spina bifida and other neural tube defectsDevelopmental Disabilities Research Reviews, 2010
- Genetics and development of neural tube defectsThe Journal of Pathology, 2009
- Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowthJournal of Neuroscience Research, 2007
- Current perspectives on the causes of neural tube defects resulting from diabetic pregnancyAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2005
- Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammationGlycobiology, 2005
- Maternal diabetes: An independent risk factor for major cardiovascular malformations with increased mortality of affected infantsTeratology, 2001
- Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.Journal of Clinical Investigation, 1995
- Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albuminsThe Protein Journal, 1995
- Lack of Relation of Increased Malformation Rates in Infants of Diabetic Mothers to Glycemic Control during OrganogenesisNew England Journal of Medicine, 1988
- Nonenzymatic Browning in Vivo: Possible Process for Aging of Long-Lived ProteinsScience, 1981